Based on our first half numbers (H1 FY24), we were "entitled" to a dividend of approximately A$0.03, but the BOD decided to hold the money, due to market conditions. As much as I like getting paid dividends, under the market conditions in early January, when that decision was made, I agreed with them, wholeheartedly.
Since spot prices for SC6, and, I would assume, PLS' financials, will look better in H2, which ends in just over a month, I would guesstimate that we would be "due" for a dividend in the A$0.05 range for H2.
PLS' BOD has been very conservative, so we might not see anything in the way of a year-end dividend. Personally, I'd like to see them give us whatever we've "earned" for H2, which I'm assuming will be approximately A$0.05, but I also think that the market would react well to us being paid our "full" year-end dividend of, assuming my numbers are accurate, A$0.08 (the amount we earn in H2 and the amount we were "due" in H1, but which they withheld).
I know we should have an idea of how Q4 went, and by extension, what our year end numbers SHOULD look like, but I believe we won't see our actual year end earnings statement until the last week in August, so it will be a while before we know who's dart hit the correct target.
Best regards,
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-43097
-
- There are more pages in this discussion • 1,295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 329137 | 3.020 |
23 | 502241 | 3.010 |
92 | 359053 | 3.000 |
16 | 98735 | 2.990 |
19 | 101042 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 32598 | 6 |
3.050 | 109743 | 7 |
3.060 | 104622 | 7 |
3.070 | 137237 | 8 |
3.080 | 1849 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online